About MS Clinical Trials Group
Clinical Trials at MS Clinical Trials Group
During the past decade, MS Clinical Trials Group conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 2 clinical trials were completed, i.e. on
average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "MS Clinical Trials Group"
#1 collaborator was "Chugai Pharmaceutical" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at MS Clinical Trials Group
According to Clinical.Site data, the most researched conditions in "MS Clinical Trials Group" are
"Multiple Sclerosis" (1 trials), "NMO Spectrum Disorder (NMOSD)" (1 trials), "Neuromyelitis Optica (NMO)" (1 trials) and "Neuromyelitis Optica Spectrum Disorder" (1 trials). Many other conditions were trialed in "MS Clinical Trials Group" in a lesser frequency.
Clinical Trials Intervention Types at MS Clinical Trials Group
Most popular intervention types in "MS Clinical Trials Group" are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Mavenclad®" (1 trials), "Placebo" (1 trials), "Satralizumab" (1 trials), "azathioprine (AZA)" (1 trials) and "mycophenolate mofetil (MMF)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at MS Clinical Trials Group
The vast majority of trials in "MS Clinical Trials Group" are
3 trials for "All" genders.
Clinical Trials Status at MS Clinical Trials Group
Currently, there are NaN active trials in "MS Clinical Trials Group".
undefined are not yet recruiting,
undefined are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in MS Clinical Trials Group,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in MS Clinical Trials Group, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".